paclitaxel has been researched along with Cerebrovascular Disorders in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, S; Choi, BW; Han, K; Hong, YJ; Hur, J; Im, DJ; Kim, JY; Kim, YJ; Lee, HJ; Suh, YJ | 1 |
Changqi, J; Changsheng, M; Chengxiong, G; Fang, C; Fangjiong, H; Jiahui, W; Jianzeng, D; Junping, K; Qiang, L; Rong, H; Shaoping, N; Shuzheng, L; Xiaohui, L; Xin, D; Xinmin, L; Xuesi, W; Yan, Q; Yin, Z; Yujie, Z | 1 |
Kang, SJ; Kim, WJ; Kim, YH; Lee, CW; Lee, JY; Lee, SW; Park, DW; Park, SJ; Park, SW; Yun, SC | 1 |
Hawkins, BM; Hennebry, TA | 1 |
Blanchard, D; Brunel, P; Carrié, D; Darremont, O; Dibie, A; Eltchaninoff, H; Fajadet, J; Gilard, M; Koning, R; Lablanche, JM; Lefèvre, T; Moynagh, A; Silvestri, M | 1 |
Chan, AT; Johnson, PJ; Leung, WT | 1 |
1 review(s) available for paclitaxel and Cerebrovascular Disorders
Article | Year |
---|---|
Local paclitaxel delivery for treatment of peripheral arterial disease.
Topics: Cerebrovascular Disorders; Drug Delivery Systems; Drug-Eluting Stents; Humans; Paclitaxel; Peripheral Arterial Disease; Popliteal Artery; Renal Artery Obstruction | 2011 |
5 other study(ies) available for paclitaxel and Cerebrovascular Disorders
Article | Year |
---|---|
SYNTAX score based on coronary computed tomography angiography may have a prognostic value in patients with complex coronary artery disease: An observational study from a retrospective cohort.
Topics: Aged; Cerebrovascular Disorders; Combined Modality Therapy; Computed Tomography Angiography; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Female; Heart Diseases; Humans; Male; Paclitaxel; Percutaneous Coronary Intervention; Postoperative Complications; Predictive Value of Tests; Prognosis; Retrospective Studies | 2017 |
Percutaneous treatment with drug-eluting stent vs bypass surgery in patients suffering from chronic stable angina with multivessel disease involving significant proximal stenosis in left anterior descending artery.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cerebrovascular Disorders; Chronic Disease; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Drug-Eluting Stents; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Registries; Reoperation; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Time Factors; Treatment Outcome | 2009 |
Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cerebrovascular Disorders; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Drug-Eluting Stents; Female; Health Status Indicators; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Registries; Reproducibility of Results; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2010 |
Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre RegIstry for stenting of uNprotecteD LMCA stenosis) registry.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cerebrovascular Disorders; Chi-Square Distribution; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Disease-Free Survival; Drug-Eluting Stents; Female; France; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Severity of Illness Index; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome | 2011 |
Cerebrovascular event following taxol infusion.
Topics: Adenocarcinoma, Mucinous; Adult; Cerebral Infarction; Cerebrovascular Disorders; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Ovarian Neoplasms; Paclitaxel; Salvage Therapy | 1994 |